More from Renaissance Capital
Referenced Stocks

Atossa Genetics prices IPO at $5, the midpoint of the range

By Renaissance Capital,  November 07, 2012, 05:12:01 PM EDT

Atossa Genetics, which develops diagnostic tests and treatments for breast cancer, raised $4 million by offering 800,000 shares at $5, the midpoint of the range of $4 to $6. Atossa Genetics plans to list on the NASDAQ under the symbol ATOS. Dawson James acted as the sole bookrunner on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks: ATOS



Latest News Video

Anthony Weiner Says More Lewd Photos Could Surface‏
Anthony Weiner Says More Lewd Photo...
Obama Heckled During Speech
Obama Heckled During Speech         
Cuomo: Shame On Us If We Elect Weiner
Cuomo: Shame On Us If We Elect Wein...
Obama Lays Out His Policies On Drones, Gitmo
Obama Lays Out His Policies On Dron...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.21 0.10  0.75%
HPQ $ 24.86 3.63  17.10%
SIRI $ 3.545 0.01  0.28%
MU $ 11.39 0.47  4.30%
MSFT $ 34.15 0.46  1.33%
F $ 14.81 0.16  1.07%
QQQ $ 73.45 0.17  0.23%
GE $ 23.66 0.20  0.84%